Dr Gupta is board certified in Psychiatry, Neuropsychiatry, Sleep Medicine and Psychosomatic Medicine. He completed his residency training from NYU followed by fellowship trainings in Psychosomatic medicine from LIJ Medical Center, Brain Imaging from Mount Sinai Hospital and Neuropsychiatry from Beth Israel Deaconess Hospital (Harvard medical School). After his extensive training he worked at LIJ Medical Center as an attending physician for 13 years. His extensive medical training and clinical experience enables him to evaluate patient at multi-dimensional levels including the understanding of brain circuits, genetic predispositions, role of neuroinflammation, psychopharmacology, interaction of sleep disorders and mood states, interactions between mind and body in health and illness etc.
‘Initial comprehensive evaluation’ is key to the development of a ‘treatment plan for depression or other psychiatric disorders. It involves multiple consideration :
- If patient meets the criteria for TMS as per criteria laid down by various medical insurance plans. Also if there is obvious contraindication for TMS treatment.
- A careful review of past history of psychopharmacological treatments, plus use of Genomind genetic studies ( if required) helps to use the best suited medication during the TMS Rx and frequently taper or discontinue the other unnecessary medications.
- Role of neuroendocrine (e.g. hypothyroidism), neuroinflammation , high stress levels or other medical illnesses is evaluated by review of detailed past history, and sometimes placing order for appropriate lab testing.
- Pre-existing sleep disorders can often contribute or exacerbate the severity of various psychiatric disorders. It is imperative to treat certain sleep disorders (like sleep apnea, psychophysiological insomnia, RLS, circadian shift disorder) so that resting brain can maintain its natural resilience, which otherwise can interfere with therapeutic gains of TMS treatment.
- Assessment of patient’s current cognitive and executive functioning and evidence of decline in recent past.
- Assessment of ongoing need for psychotherapy during the TMS for maximum gains in therapeutic outcome.